CATALYSE CAT LIMITED

Company limited by guarantee

Company Registration Number:
07504821 (England and Wales)

Unaudited micro entity accounts for the year ended 31 July 2024

Period of accounts

Start date: 01 August 2023

End date: 31 July 2024

CATALYSE CAT LIMITED

Company limited by guarantee

Contents of the Financial Statements

for the Period Ended 31 July 2024

Company Information - 3
Report of the Directors - 4
Income and Expenditure Account - 5
Balance sheet - 6
Footnotes to the Balance Sheet - 8

CATALYSE CAT LIMITED

Company limited by guarantee

Company Information

for the Period Ended 31 July 2024




Director: Prof Glenys Parry
Catherine Laverty
Sarah Littlejohn
Dr Frank Margison
Dr Dawn Bennett
Dr CL Welch
Registered office: 3
Woodcock Street
Castle Cary
Somerset
BA7 7BJ
Company Registration Number: 07504821 (England and Wales)

CATALYSE CAT LIMITED

Company limited by guarantee

Directors' Report Period Ended 31 July 2024

The directors present their report with the financial statements of the company for the period ended 31 July 2024

Principal Activities

To protect, promote and maintain health and safety of the community by promoting proper standards in the practice of cognitive analytic therapy.

Political and charitable donations

Catalyse was set up to be, over the medium term, a not for profit enterprise. Excess profits are held for future use to fund NHS staff where their authority cannot meet the full cost of training and to develop and update training methods. Help is given to students in need, but only as new funds allow.

Directors

The directors shown below have held office during the whole of the period from 01 August 2023 to 31 July 2024
Prof Glenys Parry
Catherine Laverty
Sarah Littlejohn
Dr Frank Margison
Dr Dawn Bennett
Dr CL Welch

This report was approved by the board of directors on 14 March 2025
And Signed On Behalf Of The Board By:

Name: Dr Dawn Bennett
Status: Director

CATALYSE CAT LIMITED

Company limited by guarantee

Income and Expenditure Account

for the Period Ended 31 July 2024


2024
£

2023
£
Turnover 284,634 203,117
Income from coronavirus (COVID-19) business support grants 0 0
Other Income 0 7,000
Cost of Materials ( 194,005 ) ( 150,928 )
Staff Costs ( 0 ) ( 0 )
Depreciation and Writeoffs ( 0 ) ( 0 )
Other charges ( 45,583 ) ( 51,289 )
Tax on surplus ( 8,559 ) -
Surplus or (Deficit) for Period 36,487 7,900

CATALYSE CAT LIMITED

Company limited by guarantee

Balance sheet

As at 31 July 2024


2024
£

2023
£
Fixed Assets: 0 0
Current assets: 318,001 335,433
Prepayments and accrued income: 0 0
Creditors: amounts falling due within one year: ( 244,621 ) ( 298,539 )
Net current assets (liabilities): 73,380 36,894
Total assets less current liabilities: 73,380 36,894
Creditors: amounts falling due after more than one year: ( 0 ) ( 0 )
Provision for liabilities: ( 0 ) ( 0 )
Accruals and deferred income: ( 0 ) ( 0 )
Total net assets (liabilities): 73,380 36,894
Reserves: 73,380 36,894

CATALYSE CAT LIMITED

Company limited by guarantee

Balance sheet continued

For the year ending 31 July 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 14 March 2025
And Signed On Behalf Of The Board By:

Name: Dr Dawn Bennett
Status: Director

The notes form part of these financial statements

CATALYSE CAT LIMITED

Company limited by guarantee

Footnotes to the Financial Statements

for the Period Ended 31 July 2024

  • 1. Employee Information

    Average number of employees: 0

CATALYSE CAT LIMITED

Company limited by guarantee

Footnotes to the Financial Statements

for the Period Ended 31 July 2024

  • 2. Off balance sheet disclosure

    No